Replenishment of the B cell compartment after doxorubicin-induced hematopoietic toxicity is facilitated by STAT1

Putting the brakes on mammary tumorigenesis: Loss of STAT1 predisposes to intraepithelial neoplasias

(2015) Christine Schneckenleithner et al.   Oncotarget

Loss of STAT1 from Mouse Mammary Epithelium Results in an Increased Neu-Induced Tumor Burden

(2015) Peter J. Klover et al.   NEOPLASIA

Lapatinib and doxorubicin enhance the Stat1-dependent antitumor immune response

(2013) Lára Hannesdóttir et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

The evolving contribution of hematopoietic progenitor cells to lymphomagenesis

(2012) O. Weigert et al.   BLOOD

Molecular Pathways: Interferon/Stat1 Pathway: Role in the Tumor Resistance to Genotoxic Stress and Aggressive Growth

(2012) N. N. Khodarev et al.   CLINICAL CANCER RESEARCH

MMTV-neu mice deficient in STAT1 are susceptible to develop ovarian teratomas

(2012) Lára Hannesdóttir et al.   INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY

Irgm1 protects hematopoietic stem cells by negative regulation of IFN signaling

(2011) K. Y. King et al.   BLOOD

HDAC4-Regulated STAT1 Activation Mediates Platinum Resistance in Ovarian Cancer

(2011) E. A. Stronach et al.   CANCER RESEARCH

Stat1 is a suppressor of ErbB2/Neu-mediated cellular transformation and mouse mammary gland tumor formation

(2011) Jennifer F. Raven et al.   CELL CYCLE

Modulation of IL-7 Thresholds by SOCS Proteins in Developing B Lineage Cells

(2011) S. A. Corfe et al.   JOURNAL OF IMMUNOLOGY

STAT1 and pathogens, not a friendly relationship

(2010) Imen Najjar et al.   BIOCHIMIE

Distinct Clinical Phenotypes Associated with JAK2V617F Reflect Differential STAT1 Signaling

(2010) Edwin Chen et al.   CANCER CELL

Shaping up a lineage—lessons from B lymphopoesis

(2010) David Bryder et al.   CURRENT OPINION IN IMMUNOLOGY

BCL6 is critical for the development of a diverse primary B cell repertoire

(2010) Cihangir Duy et al.   JOURNAL OF EXPERIMENTAL MEDICINE

The Functions of Signal Transducers and Activators of Transcriptions 1 and 3 as Cytokine-Inducible Proteins

(2010) HyeonJoo Cheon et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Quiescent haematopoietic stem cells are activated by IFN-γ in response to chronic infection

(2010) Megan T. Baldridge et al.   NATURE

THE CLINICAL SPECTRUM OF PATIENTS WITH DEFICIENCY OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION-1

(2010) Diana Averbuch et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Gene modulation and immunoregulatory roles of Interferonγ

(2009) Banishree Saha et al.   CYTOKINE

Selective Response to InsulinVersusInsulin-Like Growth Factor-I and -II and Up-Regulation of Insulin Receptor Splice Variant B in the Differentiated Mouse Mammary Epithelium

(2009) Chiara Berlato et al.   ENDOCRINOLOGY

Infiltrating CD11b+CD11c+cells have the potential to mediate inducible nitric oxide synthase-dependent cell death in mammary carcinomas of HER-2/neu transgenic mice

(2009) Nirmala Parajuli et al.   INTERNATIONAL JOURNAL OF CANCER

IFNα activates dormant haematopoietic stem cells in vivo

(2009) Marieke A. G. Essers et al.   NATURE

Role of STAT5 in controlling cell survival and immunoglobulin gene recombination during pro-B cell development

(2009) Stephen Malin et al.   NATURE IMMUNOLOGY

Brief Report: Interferon-γ Induces Expansion of Lin−Sca-1+C-Kit+Cells

(2009) Xin Zhao et al.   STEM CELLS

IRF8 regulates B-cell lineage specification, commitment, and differentiation

(2008) H. Wang et al.   BLOOD

An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer

(2008) R. R. Weichselbaum et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA